| Pain After Breast Surgery (NCT03307525) | Duke University | 2012-06-20 |
| Gender-Relevant Tobacco Cessation Among Women in Brazil (NCT03845413) | University of Alabama at Birmingham | 2012-06-20 |
| Azilsartan Tablets Special Drug Use Surveillance: Long-term Use (NCT02092025) | Takeda | 2012-06-20 |
| Dose Range Study of CD5789 in Acne Vulgaris (NCT01616654) | Galderma R&D | 2012-06-20 |
| A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis (NCT01565655) | Astellas Pharma Global Development, Inc. | 2012-06-19 |
| Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab (NCT01544595) | Novartis Pharmaceuticals | 2012-06-19 |
| Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer (NCT01463072) | City of Hope Medical Center | 2012-06-19 |
| Non Invasive Prenatal Diagnosis of Trisomy 21 by Genetic Analysis of Circulating Fetal Cells (NCT01725438) | Assistance Publique - Hôpitaux de Paris | 2012-06-19 |
| Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM) (NCT01587144) | Spectrum Pharmaceuticals, Inc | 2012-06-19 |
| Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation Study (NCT01469169) | Bayer | 2012-06-19 |
| Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers (NCT01624766) | M.D. Anderson Cancer Center | 2012-06-19 |
| Systems Intervention to Promote Colorectal Cancer (CRC) Screening (NCT01299493) | Washington University School of Medicine | 2012-06-19 |
| SpO2 System Accuracy Testing With Different Sensors (NCT01613222) | GE Healthcare | 2012-06-19 |
| European New Texture Implant Clinical Experience With Shaped Breast Implants (NCT01639755) | Allergan | 2012-06-18 |
| European New Texture Implant Clinical Experience With Round Breast Implants (NCT01639742) | Allergan | 2012-06-18 |
| Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival (NCT01574170) | Institut Claudius Regaud | 2012-06-18 |
| Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia (NCT01535053) | GOG Foundation | 2012-06-18 |
| National Eye Institute Biorepository for Retinal Diseases (NCT01496625) | National Eye Institute (NEI) | 2012-06-18 |
| Post Market Clinical Follow-Up of Plasmafit® Cup (NCT02019849) | Aesculap AG | 2012-06-18 |
| Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma (NCT01614795) | National Cancer Institute (NCI) | 2012-06-18 |
| Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT00719303) | Gynecologic Oncology Group | 2012-06-18 |
| Effects of Mouth-opening Training on the Maximum Interincisal Opening (NCT03875118) | National Taipei University of Nursing and Health Sciences | 2012-06-18 |
| Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer (NCT01607905) | Karyopharm Therapeutics Inc | 2012-06-18 |
| Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies (NCT01607957) | Taiho Oncology, Inc. | 2012-06-17 |
| Genetics and Pain Severity in Sickle Cell Disease (NCT01441141) | National Heart, Lung, and Blood Institute (NHLBI) | 2012-06-17 |
| Socket Augmentation Using Platelet Concentrates, Atorvastatin Gel or Combination (NCT03231137) | Ain Shams University | 2012-06-16 |
| HPV Vaccination Among Daughters of Latina Immigrants (NCT04154319) | University of Alabama at Birmingham | 2012-06-15 |
| Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity (NCT01636544) | Institut Pasteur | 2012-06-15 |
| Acceptance and Commitment Therapy for Adolescents and Young Adults With Neurofibromatosis and Chronic Pain (NCT01633008) | National Cancer Institute (NCI) | 2012-06-15 |
| Randomized Trial of the Impact of Body Scanning and Intensive Behavioral Intervention on Behavioral Change and Health Outcomes (NCT03392350) | Reengineering Healthcare Inc. | 2012-06-15 |
| Post Traumatic Stress Among Relatives of Brain-dead, Withdrawal of Life Support, and Sudden Death Patients (NCT01412502) | Centre Hospitalier Universitaire de Nīmes | 2012-06-15 |
| Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD) (NCT01591863) | Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2012-06-15 |
| A Web-Based Multimedia Intervention for Head and Neck Cancer Patients (NCT02442336) | Fox Chase Cancer Center | 2012-06-15 |
| A Study of Selumetinib in Patients With Kaposi's Sarcoma (NCT01752569) | Sheffield Teaching Hospitals NHS Foundation Trust | 2012-06-15 |
| A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer (NCT01616303) | Quest PharmaTech Inc. | 2012-06-15 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma (NCT01703481) | Janssen Research & Development, LLC | 2012-06-15 |
| Therapy De-escalation in Seminoma Stage IIA/B (NCT01593241) | Swiss Cancer Institute | 2012-06-15 |
| Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela ) (NCT01569295) | Gilead Sciences | 2012-06-15 |
| Mandibular Overdenture Clinical Trial Comparing Parallel Sided and Tapered Dental Implants (NCT03272828) | University of Washington | 2012-06-15 |
| Dolutegravir Expanded Access Study (NCT01536873) | ViiV Healthcare | 2012-06-14 |
| Network Pharmacology Prediction: Mechanism Study of Puerarin in the Treatment of Giant Cell Tumors of Bone (NCT06331104) | Changye Zou | 2012-06-14 |
| TIRCON International NBIA Registry (NCT05522374) | LMU Klinikum | 2012-06-14 |
| A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma (NCT01569750) | Janssen Research & Development, LLC | 2012-06-14 |
| Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir (NCT01598090) | Bristol-Myers Squibb | 2012-06-14 |
| Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas (NCT01560949) | M.D. Anderson Cancer Center | 2012-06-14 |
| Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors (NCT01765790) | Baxalta now part of Shire | 2012-06-14 |
| Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment (NCT01620489) | Novo Nordisk A/S | 2012-06-14 |
| Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE) (NCT01838512) | Bristol-Myers Squibb | 2012-06-13 |
| A Study to Continue ASP015K Treatment to Rheumatoid Arthritis Patients Who Completed Phase IIb Study or Phase III Study of ASP015K (NCT01638013) | Astellas Pharma Inc | 2012-06-13 |
| ADjunctive coRticosteroid trEatment iN criticAlly ilL Patients With Septic Shock (NCT01448109) | The George Institute | 2012-06-13 |
| Living With Frontotemporal Dementia (NCT01738386) | National Human Genome Research Institute (NHGRI) | 2012-06-13 |
| Acupressure and Stress Resilience (NCT01614444) | VA Eastern Colorado Health Care System | 2012-06-13 |
| 18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain (NCT01621906) | Memorial Sloan Kettering Cancer Center | 2012-06-13 |
| A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer (NCT01525589) | PharmaMar | 2012-06-13 |
| Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery (NCT01791088) | University of Chicago | 2012-06-13 |
| Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS) (NCT01600716) | Allergan | 2012-06-13 |
| PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery (NCT01515787) | Alliance for Clinical Trials in Oncology | 2012-06-12 |
| Pediatric Obesity Treatment in a Safety Net Clinic: Piloting the Step by Step Program (NCT04297228) | Community Volunteers In Medicine | 2012-06-12 |
| Invasiveness and Chemoresistance of Cancer Stem Cells in Colon Cancer (NCT01577511) | Centre Hospitalier Universitaire de Nīmes | 2012-06-12 |
| TXA Study in Major Oncologic Surgery (NCT01980355) | Corewell Health West | 2012-06-12 |
| A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment. (NCT01638000) | Astellas Pharma Europe Ltd. | 2012-06-12 |
| An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357) (NCT01498445) | M.D. Anderson Cancer Center | 2012-06-12 |
| Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation (NCT01606995) | Bayer | 2012-06-12 |
| Impact on the Nutritional State and the Quality of Life (NCT01687335) | Assistance Publique Hopitaux De Marseille | 2012-06-12 |
| Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (NCT01482962) | Millennium Pharmaceuticals, Inc. | 2012-06-11 |
| Peripheral Primitive Fibromatosis (NCT01801176) | Gustave Roussy, Cancer Campus, Grand Paris | 2012-06-11 |
| Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery (NCT01473940) | Northwestern University | 2012-06-11 |
| Carboplatin in Treating Patients With Recurrent High-Grade Gliomas (NCT01644955) | James Elder | 2012-06-11 |
| Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms (NCT01520220) | Eli Lilly and Company | 2012-06-11 |
| The Effect of Mid-urethral Sling on the Urethral Dynamic Shape and Motion (NCT04843995) | Endeavor Health | 2012-06-11 |
| A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) (NCT01578499) | Millennium Pharmaceuticals, Inc. | 2012-06-11 |
| BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115 (NCT01597622) | GlaxoSmithKline | 2012-06-11 |
| Consequences of At-risk Alcohol Consumption in ICU Patients (NCT03565016) | Nantes University Hospital | 2012-06-11 |
| PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - Nested Registry 3/Valve-in-Valve (NCT03225001) | Edwards Lifesciences | 2012-06-11 |
| A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 Diabetes (NCT01618188) | Novo Nordisk A/S | 2012-06-11 |
| Massive Iron Deposit Assessment (NCT01572922) | St. Jude Children's Research Hospital | 2012-06-11 |
| Effect of Physical Activity in Women With Manifest Osteporosis (NCT04768712) | Sahlgrenska University Hospital | 2012-06-10 |
| BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma (NCT01512251) | University of California, San Francisco | 2012-06-09 |
| To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer (NCT01496313) | Sanofi | 2012-06-08 |
| Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma (NCT01579318) | OncoSec Medical Incorporated | 2012-06-08 |
| Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis. (NCT01623596) | Novartis Pharmaceuticals | 2012-06-08 |
| Individual Differences in Reward and Impulse Control (NCT01621607) | National Institute on Drug Abuse (NIDA) | 2012-06-08 |
| Developpement of 3T MRI Protocol (NCT05090956) | Institut National de la Santé Et de la Recherche Médicale, France | 2012-06-08 |
| Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma (NCT01643824) | National Cancer Center, Korea | 2012-06-07 |
| Long Term Split Belt Treadmill Training for Stroke Recovery (NCT01646216) | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 2012-06-07 |
| Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B (NCT01386528) | Novo Nordisk A/S | 2012-06-07 |
| Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy (NCT01513759) | Boston Scientific Corporation | 2012-06-07 |
| A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug (NCT01565707) | Astellas Pharma Europe B.V. | 2012-06-07 |
| Development of MRI Protocols and Associated Explorations (EEG, NIRS) in Healthy Volunteers (NCT03152539) | University Hospital, Grenoble | 2012-06-07 |
| Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea (NCT01557166) | Novo Nordisk A/S | 2012-06-07 |
| Modulating Neuropathic Pain With Transcranial Direct Current Stimulation (NCT04581525) | Susan McDowell | 2012-06-07 |
| Young-Onset Colorectal Cancer (NCT02863107) | M.D. Anderson Cancer Center | 2012-06-07 |
| Trimodal Prehabilitation in Patients Undergoing Elective Surgery (NCT05114408) | Medical University of Gdansk | 2012-06-07 |
| BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology (NCT01660776) | Rennes University Hospital | 2012-06-07 |
| Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw (NCT01846195) | Zynex Monitoring Solutions | 2012-06-06 |
| Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia (NCT01839240) | University of Chicago | 2012-06-06 |
| Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia (NCT01629082) | National Heart, Lung, and Blood Institute (NHLBI) | 2012-06-06 |
| A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors (NCT01525550) | Pfizer | 2012-06-06 |
| Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (NCT01619085) | Boehringer Ingelheim | 2012-06-06 |
| A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer (NCT01756638) | Janssen Research & Development, LLC | 2012-06-06 |